IFN-α production by plasmacytoid dendritic cell associations with polymorphisms in gene loci related to autoimmune and inflammatory diseases

Human Molecular Genetics

Volumn 24, Issue 12, 2015, Pages 3571-3581

  Berggren, Olof ^a   Alexsson, Andrei ^a   Morris, David L ^b   Tandre, Karolina ^a   Weber, Gert ^c   Vyse, Timothy J ^b   Syvänen, Ann Christine ^a   Rönnblom, Lars ^a   Eloranta, Maija Leena ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b GUY S HOSPITAL   (United Kingdom)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERFERON REGULATORY FACTOR 5; OLIGONUCLEOTIDE; RNA; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL FUNCTION; CELL ISOLATION; CELLS BY BODY ANATOMY; CHROMOSOME; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; AUTOIMMUNE DISEASES; BIOSYNTHESIS; CASE CONTROL STUDY; DENDRITIC CELL; GENE REGULATORY NETWORK; GENETIC POLYMORPHISM; GENETICS; IMMUNOLOGY; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLISM; MIDDLE AGED; YOUNG ADULT;

SIMPLEXVIRUS;

ADULT; AGED; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; DENDRITIC CELLS; FEMALE; GENE REGULATORY NETWORKS; GENETIC LOCI; GENOTYPE; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTORS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84930440712     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddv095     Document Type: Article

References (55)

1. Eloranta, M.-L., Alm, G.V. and Rönnblom, L. (2013) Disease mechanisms in rheumatology-tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases. Arthritis Rheum., 65, 853-863.
2. Rönnblom, L. and Eloranta, M.-L. (2013) The interferon signature in autoimmune diseases. Curr. Opin. Rheumatol., 25, 248-253.
3. Bronson, P., Chaivorapol, C., Ortmann, W., Behrens, T. and Graham, R. (2012) The genetics of type I interferon in systemic lupus erythematosus. Curr. Opin. Immunol., 24, 530-537.
4. Deng, Y. and Tsao, B.P. (2014) Advances in lupus genetics and epigenetics. Curr. Opin. Rheumatol., 26, 482-492.
5. Fitzgerald-Bocarsly, P., Dai, J. and Singh, S. (2008) Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history. Cytokine Growth Factor Rev., 19, 3-19.
6. Reizis, B., Bunin, A., Ghosh, H., Lewis, K. and Sisirak, V. (2011) Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol., 29, 163-183.
7. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdörfer, B., Blackwell, S., Ballas, Z., Endres, S., Krieg,A. and Hartmann, G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmacytoid dendritic cells. Eur. J. Immunol., 31, 2154-2163.
8. Rönnblom, L. (2011) The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups. J. Med. Sci., 116, 227-237.
9. Eloranta, M.-L., Lövgren, T., Finke, D., Mathsson, L., Rönnelid, J., Kastner, B., Alm, G.V. and Rönnblom, L. (2009) Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells. Arthritis Rheum., 60, 2418-2427.
10. Hagberg, N., Berggren, O., Leonard, D.,Weber, G., Bryceson, Y. T., Alm, G.V., Eloranta, M.-L. and Rönnblom, L. (2011) IFNalpha production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes is promoted by NK cells via MIP-1beta and LFA-1. J. Immunol., 186, 5085-5094.
11. Berggren, O., Hagberg, N., Weber, G., Alm, G.V., Rönnblom, L. and Eloranta, M.-L. (2012) B lymphocytes enhance interferonalpha production by plasmacytoid dendritic cells. Arthritis Rheum., 64, 3409-3419.
12. Båve, U., Magnusson, M., Eloranta, M.-L., Perers, A., Alm, G.V. and Rönnblom, L. (2003) Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J. Immunol., 171, 3296-3302.
13. Means, T.K., Latz, E., Hayashi, F., Murali, M.R., Golenbock, D.T. and Luster, A.D. (2005) Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest., 115, 407-417.
14. Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., Akira, S., Kelly, K.M., Reeves,W.H., Bauer, S. et al. (2005) Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med., 202, 1575-1585.
15. Sigurdsson, S., Nordmark, G., Göring, H.H., Lindroos, K., Wiman, A.C., Sturfelt, G., Jönsen, A., Rantapää-Dahlqvist, S., Möller, B., Kere, J. et al. (2005) Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am. J. Hum. Genet., 76, 528-537.
16. Sigurdsson, S., Nordmark, G., Garnier, S., Grundberg, E., Kwan, T., Nilsson, O., Eloranta, M.-L., Gunnarsson, I., Svenungsson, E., Sturfelt, G. et al. (2008) A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum. Mol. Genet., 17, 2868-2876.
17. Sigurdsson, S., Göring, H.H., Kristjansdottir, G., Milani, L., Nordmark, G., Sandling, J., Eloranta, M.-L., Feng, D., Sangster-Guity, N., Gunnarsson, I. et al. (2008) Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus. Hum. Mol. Genet., 17, 872-881.
18. Gateva, V., Sandling, J., Hom, G., Taylor, K., Chung, S., Sun, X., Ortmann,W., Kosoy, R., Ferreira, R., Nordmark, G. et al. (2009) A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus. Nat. Genet., 41, 1228-1233.
19. Sandling, J., Garnier, S., Sigurdsson, S., Wang, C., Nordmark, G., Gunnarsson, I., Svenungsson, E., Padyukov, L., Sturfelt, G., Jönsen, A. et al. (2011) A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE. Eur. J. Hum. Genet., 19, 479-484.
20. Cunninghame Graham, D.S., Morris, D.L., Bhangale, T.R., Criswell, L.A., Syvanen, A.C., Rönnblom, L., Behrens, T.W., Graham, R.R. and Vyse, T.J. (2011) Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet., 7, e1002341.
21. Nath, S.,Harley, J. and Lee,Y. (2005) Polymorphisms of complement receptor 1 and interleukin-10 genes and systemic lupus erythematosus: a meta-analysis. Hum. Genet., 118, 225-234.
22. Han, J.-W., Zheng, H.-F., Cui, Y., Sun, L.-D., Ye, D.-Q., Hu, Z., Xu, J.-H., Cai, Z.-M., Huang, W., Zhao, G.-P. et al. (2009) Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat. Genet., 41, 1234-1237.
23. Sullivan, K., Piliero, L., Dharia, T., Goldman, D. and Petri, M. (2000) 3′ polymorphisms of ETS1 are associated with different clinical phenotypes in SLE. Hum. Mutat., 16, 49-53.
24. Wang, B., Zhu, J.-M., Fan, Y.-G., Xu, W.-D., Cen, H., Pan, H.-F. and Ye, D.-Q. (2013) Association of the -1082G/A polymorphism in the interleukin-10 gene with systemic lupus erythematosus:a meta-analysis. Gene, 519, 209-216.
25. Harley, J.B., Alarcon-Riquelme, M.E., Criswell, L.A., Jacob, C.O., Kimberly, R.P., Moser, K.L., Tsao, B.P., Vyse, T.J., Langefeld, C. D., Nath, S.K. et al. (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat. Genet., 40, 204-210.
26. Perricone, C., Ciccacci, C., Ceccarelli, F., Di Fusco, D., Spinelli, F., Cipriano, E., Novelli, G., Valesini, G., Conti, F. and Borgiani, P. (2013) TRAF3IP2 gene and systemic lupus erythematosus:association with disease susceptibility and pericarditis development. Immunogenetics, 65, 703-709.
27. Niewold, T., Kelly, J., Flesch, M., Espinoza, L., Harley, J. and Crow, M. (2008) Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum., 58, 2481-2487.
28. Kottyan, L.C., Zoller, E.E., Bene, J., Lu, X., Kelly, J.A., Rupert, A. M., Lessard, C.J., Vaughn, S.E., Marion, M., Weirauch, M.T. et al. (2015) The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. Hum. Mol. Genet., 24, 582-596.
29. Wahren-Herlenius, M. and Dörner, T. (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet, 382, 819-831.
30. Gary-Gouy, H., Lebon, P. and Dalloul, A. (2002) Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J. Interferon Cytokine Res., 22, 653-659.
31. Naranjo-Gómez, M., Oliva, H., Climent, N., Fernández, M., Ruiz-Riol, M., Bofill, M., Gatell, J., Gallart, T., Pujol-Borrell, R. and Borràs, F. (2007) Expression and function of the IL-2 receptor in activated human plasmacytoid dendritic cells. Eur. J. Immunol., 37, 1764-1772.
32. Hansen, M., Woetmann, A., Krejsgaard, T., Kopp, K., Søkilde, R., Litman, T., Straten, P., Geisler, C.,Wasik, M., Odum, N. et al. (2011) IFN-α primes T-and NK-cells for IL-15-mediated signaling and cytotoxicity. Mol. Immunol., 48, 2087-2093.
33. Liao,W., Lin, J.-X. and Leonard,W. (2013) Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. Immunity, 38, 13-25.
34. Leng, R.-X., Pan, H.-F., Chen, G.-M., Feng, C.-C., Fan, Y.-G., Ye, D.-Q. and Li, X.-P. (2011) The dual nature of Ets-1: focus to the pathogenesis of systemic lupus erythematosus. Autoimmun. Rev, 10, 439-443.
35. Geisler, S. and Coller, J. (2013) RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat. Rev. Mol. Cell Biol., 14, 699-712.
36. Takeuchi, H., Takeuchi, T., Gao, J., Cantley, L. and Hirata, M. (2010) Characterization of PXK as a protein involved in epidermal growth factor receptor trafficking. Mol. Cell. Biol., 30, 1689-1702.
37. Park, Y., Lee, S., Kim, D., Lee, J., Lee, C. and Song, C. (1998) Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin. Exp. Rheumatol., 16, 283-288.
38. Yao, Y., Simard, A., Shi, F.-D. and Hao, J. (2013) IL-10-producing lymphocytes in inflammatory disease. Int. Rev. Immunol., 32, 324-336.
39. Ryzhakov, G., Blazek, K., Lai, C.C. and Udalova, I.A. (2012) IL-17 receptor adaptor protein Act1/CIKS plays an evolutionarily conserved role in antiviral signaling. J. Immunol., 189, 4852-4858.
40. Lu, X., Zhang, N., Meng, B., Dong, S. and Hu, Y. (2012) Involvement of GPR12 in the regulation of cell proliferation and survival. Mol. Cell. Biochem., 366, 101-110.
41. Fu, Y., Kim, I., Lian, P., Li, A., Zhou, L., Li, C., Liang, D., Coffey, R., Ma, J., Zhao, P. et al. (2010) Loss of Bicc1 impairs tubulomorphogenesis of cultured IMCD cells by disrupting E-cadherinbased cell-cell adhesion. Eur. J. Cell Biol., 89, 428-436.
42. Gabr, M., Jing, L., Helbling, A., Sinclair, S., Allen, K., Shamji, M., Richardson, W., Fitch, R., Setton, L. and Chen, J. (2011) Interleukin-17 synergizes with IFNγ or TNFα to promote inflammatory mediator release and intercellular adhesion molecule-1 (ICAM-1) expression in human intervertebral disc cells. J. Orthop. Res., 29, 1-7.
43. Chen, H., Zhang, D., Wang, S., Wang, X. and Yang, C. (2013) Significance of correlation between interferon-γ and soluble intercellular adhesion molecule-1 and interleukin-17 in hepatitis B virus-related cirrhosis. Clin. Res. Hepatol. Gastroenterol., 37, 608-613.
44. Tatin, F., Taddei, A.,Weston, A., Fuchs, E., Devenport, D., Tissir, F. and Makinen, T. (2013) Planar cell polarity protein Celsr1 regulates endothelial adherens junctions and directed cell rearrangements during valve morphogenesis. Dev. Cell, 26, 31-44.
45. Sullivan, L., Clements, C., Rossjohn, J. and Brooks, A. (2008) The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens, 72, 415-424.
46. Guzman-Fulgencio, M., Berenguer, J., Rallon, N., Fernandez-Rodriguez, A., Miralles, P., Soriano, V., Jimenez-Sousa, M.A., Cosin, J., Medrano, J., Garcia-Alvarez, M. et al. (2013) HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy. AIDS, 27, 1231-1238.
47. Stone, R.C., Du, P., Feng, D., Dhawan, K., Rönnblom, L., Eloranta, M.-L., Donnelly, R. and Barnes, B.J. (2013) RNA-Seq for enrichment and analysis of IRF5 transcript expression in SLE. PLoS ONE, 8, e54487.
48. Piganis, R.A., De Weerd, N.A., Gould, J.A., Schindler, C.W., Mansell, A., Nicholson, S.E. and Hertzog, P.J. (2011) Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J. Biol. Chem., 286, 33811-33818.
49. O'Shea, J.J. and Plenge, R. (2012) JAK and STAT signaling molecules in immunoregulation and immune-mediated disease. Immunity, 36, 542-550.
50. Cederblad, B., Blomberg, S., Vallin, H., Perers, A., Alm, G.V. and Rönnblom, L. (1998) Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha-producing cells. J. Autoimmun., 11, 465-470.
51. Weber, G., Trowitzsch, S., Kastner, B., Luhrmann, R. and Wahl, M.C. (2010) Functional organization of the Sm core in the crystal structure of human U1 snRNP. EMBO J., 29, 4172-4184.
52. Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S. and Endres, S. (2003) Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol., 33, 1633-1641.
53. Stranger, B.E., Montgomery, S.B., Dimas, A.S., Parts, L., Stegle, O., Ingle, C.E., Sekowska, M., Smith, G.D., Evans, D., Gutierrez-Arcelus, M. et al. (2012) Patterns of cis regulatory variation in diverse human populations. PLoS Genet., 8, e1002639.
54. Hom, G., Graham, R., Modrek, B., Taylor, K., Ortmann,W., Garnier, S., Lee, A., Chung, S., Ferreira, R., Pant, P. et al. (2008) Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N. Engl. J. Med., 358, 900-909.
55. Pers, T.H., Karjalainen, J.M., Chan, Y.,Westra, H.J.,Wood, A.R., Yang, J., Lui, J.C., Vedantam, S., Gustafsson, S., Esko, T. et al. (2015) Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun., 6, 5890.